Pure embryonal carcinoma of the ovary. Case report and review of the literature;Carcinome embryonnaire pur de l'ovaire. Revue de la litterature a propos d'un cas

Bulletin du Cancer

Volumn 83, Issue 9, 1996, Pages 718-724

  Hulewicz, G ^a   Golfier, F ^b   Chatte, G ^a   Vitrey, D ^b   Martel, I ^a   Raudrant, D ^b   Trillet Lenoir, V ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b HÔTEL DIEU   (France)

Author keywords

AFP; chemotherapy; embryonal carcinoma; germ cell tumor; HCG; ovary; second look laparotomy

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR;

ADULT; ARTICLE; CASE REPORT; EMBRYONAL CARCINOMA; FEMALE; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; OVARY CARCINOMA; SECOND LOOK SURGERY; THROMBOCYTOPENIA;

ADULT; ALPHA-FETOPROTEINS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASCITES; CARCINOMA, EMBRYONAL; CHORIONIC GONADOTROPIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; PROGNOSIS; REOPERATION; TUMOR MARKERS, BIOLOGICAL;

EID: 0029771632     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Berek JS. Non epithelial ovarian tumors. In: Holland JF, Frei E, Bast RC, eds. Cancer Med 1993;XXXI:1667-83
2. Bosl GJ, Geller NL, Cirrincione C et al. Multivariate analysis of pronostic variables in patients with metastatic testicular cancer. Cancer Res 1983;43:3403-7
3. Creasman WT, Fetter B, Hammond CB et al. Germ cell malignancies of the ovary. Obstet Gynecol 1979;53:226-30
4. Culine S, Kattan J, Lhomme C et al. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary. Gynecol Oncol 1994; 54:47-53
5. Daugaard G, Hansen H, Rorth M. Treatment of malignant germ cell tumors. Ann Oncol 1990;1:195-202
6. De Palo G, Zambetti M, Piloppi S et al. Non dysgerminomatous tumors of the ovary treated with cisplatin, vinblastine, and bleomycin: long-term results. Gynecol Oncol 1992;47:239-46
7. Dos Santos Silva I, Swerdlow A. Ovarian germ cell malignancies in England: epidemiological parallels with testicular cancer. Br J Cancer 1991;63:814-8
8. Droz JP, Kramar A, Rey A. Prognostic factors in metastatic disease. Semin Oncol 1992;19:181-9.
9. Fung C, Kalis LA, Brodsky GL et al. Stage I non-seminomatous germ cell testicular tumor: prediction of metastatic potential by primary histology. J Clin Oncol 1988;6: 1467-73
10. Germa J, Izquierdo M, Segui M et al. Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau. Gynecol Oncol 1992;45:153-9
11. Gershenson DM, Del Junco G, Copeland JL et al. Mixed germ cell tumors of the ovary. Obstet Gynecol 1984;64: 200-6
12. Gershenson D, Copeland L, Kavanagh J et al. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin and cyclophosphamide. Cancer 1985;56:2756-61
13. Gershenson D, Copeland L, Del Junco G et al. Second look laparotomy in the management of ovarian germ cell tumors. Obstet Gynecol 1986;67:789-93
14. Gershenson D, Kavanagh J, Copeland L et al. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatin. Cancer 1986;57:1731-7
15. Gershenson D, Morris M, Kavanagh J et al. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 1990;8:715-20
16. Gershenson D. Update on malignant ovarian germ cell tumors. Cancer 1993;71:1581-90
17. International Federation of Gynecology and Obstetric. Change in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987;156:246
18. Jacobs AJ, Harris M, Deppe G et al. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine and bleomycin. Obstet Gynecol 1982;59:129-32
19. Kawaï M, Furuhashi Y, Kano T et al. Alpha fetoprotein in malignant germ cell tumors of the ovary. Gynecol Oncol 1990;39:160-6
20. Kurman R, Norris J. Embryonal carcinoma of the ovary. Cancer 1976;38:2420-33
21. Lapola J, Fiorica J, Turnquist D et al. Successful therapy of metastatic embryonal carcinoma coexisting with gonadoblastoma in a patient with 46, XY pure gonadal dysgenesis (Swyer's Syndrome). Gynecol Oncol 1990;37:417-21
22. Maffeo A, Stellato G. Embryonal carcinoma of the ovary. Anatomo-clinical aspects and presentation of a case. Minerva Ginecol 1989;41:241-5
23. Martinazzi M, Bertoli G, Crivelli F et al. Mixed ovarian germ cell neoplasia: adult embryonal carcinoma and dysgerminoma with trophoblasts. Pathologica 1989;81:537-42
24. Mayordomo J, Paz-Ares L, Rivera F et al. Ovarian and extragonadal malignant germ-cell tumors in female: a single-institution experience with 43 patients. Ann Oncol 1994;5:225-31
25. Miyazaki C, Karo R, Nishimura N et al. A case of embryonal carcinoma of the ovary occured in a 50 year-old woman. Nippon Sanka Fujinka Gakkai Zasshi 1992;44:483-6
26. Nakakuma K, Tashiro S, Uemura K, Takayama K. Alpha-fetoprotein and human chorionic gonadotrophin in embryonal carcinoma of the ovary. Cancer 1983;52:1470-2
27. Newlands E, Southall P, Paradinas F, Holden L. Management of ovarian germ cell tumors. In: Williams CJ, Krikorian JG, Greenand MR, Ragharan D, eds. Textbook of uncommon cancer. John Wiley & Sons Ltd, 1988;3:37-53
28. Pippitt C, Cain J, Hackes T et al. Primary chemotherapy and the role of second look laparotomy in non-dysgerminomatous germ cell malignancies of the ovary. Gynecol Oncol 1988;431:268-75
29. Schwartz PE. Ovarian germ cell malignancies. The Yale University Experience. Gynecol Oncol 1992;45:26-31
30. Serov SF, Scully RE, Solvin LH et al. International histological classification of tumors No 9. Histological typing of ovarian tumors. Geneva: World Health Organisation, 1973
31. Slayton RE. Management of germ cell and stromal tumors of the ovary. Semin Oncol 1984;11:299-313
32. Slayton R, Parck R, Silverberg S et al. Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. Cancer 1985;56:243-8
33. Smales E, Peckham M. Chemotherapy of germ cell ovarian tumors : first-line treatment with etoposide, bleomycin and cisplatin or arboplatin. Eur J Cancer Clin Oncol 1987;23: 469-74
34. Taylor M, Depetrillo A, Turner R. Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovary. Cancer 1985;56:1341-9
35. Veda G, Abe Y, Yoshida M. Embryonal carcinoma of the ovary: a six year survival. Int J Gynecol Obstet 1990;31: 287-92
36. Williams S, Birch R, Einhorn L et al. Treatment of disseminated germ cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987;316:1435-9
37. Williams SD. Cisplatinum, vinblastine and bleomycin in advanced and recurent ovarian germ cell tumors. A trial of the Gynecologic Oncologic Group. Ann Intern Med 1989:111:22-7
38. Williams S. Treatment of germ cell tumors of the ovary. Semin Oncol 1991;18:292-6
39. Williams S, Blessing J, Liao S, Ball H, Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncologic Group. J Clin Oncol 1994;12:701-6
40. Williams SD, Blessing JA, Disaia PJ et al. Second look laparotomy in ovarian germ cell tumors: the Gynecologic Oncologic Group experience. Gynecol Oncol 1994;52: 287-91